Kymera Therapeutics

1 Follower


Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Bruce Jacobs
Richard Chesworth
Chief Scientific Officer
Jared Gollob
Chief Medical Officer
Elaine Caughey
Chief Business Officer
Ashwin Gollerkeri
SVP, Head of Development
Brian Albarran
VP, Strategy & Operations
Paige Cochran
Karen Martin
VP, Head of Legal
Kevin Dushney
Karen Weisbach
VP, People & Culture
Jolly Bhatia
VP, Quality

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.